Search Results - "Mohr, Amanda L.A."

Refine Results
  1. 1

    Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities—2021 Update by D’Orazio, Amanda L, Mohr, Amanda L.A, Chan-Hosokawa, Ayako, Harper, Curt, Huestis, Marilyn A, Limoges, Jennifer F, Miles, Amy K, Scarneo, Colleen E, Kerrigan, Sarah, Liddicoat, Laura J, Scott, Karen S, Logan, Barry K

    Published in Journal of analytical toxicology (10-07-2021)
    “…Abstract This report describes updates to the National Safety Council’s Alcohol, Drugs and Impairment Division’s recommendations for drug testing in driving…”
    Get full text
    Journal Article
  2. 2

    Analysis of Novel Synthetic Opioids U-47700, U-50488 and Furanyl Fentanyl by LC-MS/MS in Postmortem Casework by Mohr, Amanda L A, Friscia, Melissa, Papsun, Donna, Kacinko, Sherri L, Buzby, David, Logan, Barry K

    Published in Journal of analytical toxicology (01-11-2016)
    “…Following series of synthetic cannabinoid and synthetic cathinone derivatives, the illicit drug market has begun to see increased incidence of synthetic…”
    Get full text
    Journal Article
  3. 3

    Xylazine: Pharmacology Review and Prevalence and Drug Combinations in Forensic Toxicology Casework by Kacinko, Sherri L, Mohr, Amanda L A, Logan, Barry K, Barbieri, Edward J

    Published in Journal of analytical toxicology (14-10-2022)
    “…Abstract Xylazine, an alpha-2 receptor agonist used in veterinary medicine for its sedative and muscle-relaxant effects, has been reported in forensic…”
    Get full text
    Journal Article
  4. 4

    Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review by Logan, Barry K., Mohr, Amanda L.A., Friscia, Melissa, Krotulski, Alex J., Papsun, Donna M., Kacinko, Sherri L., Ropero-Miller, Jeri D., Huestis, Marilyn A.

    Published in Journal of analytical toxicology (01-09-2017)
    “…Abstract Novel psychoactive substances (NPS) represent significant analytical and interpretive challenges to forensic and clinical toxicologists. Timely access…”
    Get full text
    Journal Article
  5. 5

    Four-year evaluation of drug-impaired driving drug concentrations by Cieri, Grace, Mohr, Amanda L A, Fogarty, Melissa, Chan-Hosokawa, Aya, Logan, Barry K

    Published in Journal of analytical toxicology (15-11-2024)
    “…Drug-impaired driving is a significant public health and safety concern in the USA. To help assess current patterns of drug use in drivers, we evaluated 4…”
    Get full text
    Journal Article
  6. 6

    Evaluating cross-reactivity of new psychoactive substances (NPS) in human whole blood by enzyme-linked immunosorbent assay (ELISA) by Cieri, Grace, Mohr, Amanda L A, Mastrovito, Rebecca, Logan, Barry K

    Published in Journal of analytical toxicology (28-03-2024)
    “…Due to the increase in the use of novel psychoactive substances (NPS) and their overall prevalence, it is important to have effective and reliable screening…”
    Get full text
    Journal Article
  7. 7

    Hide and Seek: Overcoming the Masking Effect of Opioid Antagonists in Activity-Based Screening Tests by Cannaert, Annelies, Deventer, Marie, Fogarty, Melissa, Mohr, Amanda L A, Stove, Christophe P

    Published in Clinical chemistry (Baltimore, Md.) (01-12-2019)
    “…To the Editor: We previously reported on an alternative activity-based screening method to detect (synthetic) opioids/opiates in blood samples (1) in which…”
    Get full text
    Journal Article
  8. 8

    Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment by Krotulski, Alex J, Bishop-Freeman, Sandra C, Mohr, Amanda L A, Logan, Barry K

    Published in Journal of analytical toxicology (06-02-2021)
    “…Abstract Synthetic cannabinoids represent a chemically diverse class of novel psychoactive substances (NPS) responsible for large analytical and interpretative…”
    Get full text
    Journal Article
  9. 9

    N-Ethyl Pentylone (Ephylone) Intoxications: Quantitative Confirmation and Metabolite Identification in Authentic Human Biological Specimens by Krotulski, Alex J, Papsun, Donna M, De Martinis, Bruno S, Mohr, Amanda L A, Logan, Barry K

    Published in Journal of analytical toxicology (01-09-2018)
    “…N-ethyl pentylone (ephylone) has been identified as the most recent novel stimulant to emerge into the arena of evolving novel psychoactive substances (NPS)…”
    Get full text
    Journal Article
  10. 10

    Emerging Synthetic Cannabinoids: Development and Validation of a Novel Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry Assay for Real-Time Detection by Krotulski, Alex J, Mohr, Amanda L A, Logan, Barry K

    Published in Journal of analytical toxicology (30-04-2020)
    “…Abstract Synthetic cannabinoids pose significant threats to public health and safety, as their implications in overdose and adverse events continue to arise in…”
    Get full text
    Journal Article
  11. 11

    Activity-Based Concept to Screen Biological Matrices for Opiates and (Synthetic) Opioids by Cannaert, Annelies, Vasudevan, Lakshmi, Friscia, Melissa, Mohr, Amanda L A, Wille, Sarah M R, Stove, Christophe P

    Published in Clinical chemistry (Baltimore, Md.) (01-08-2018)
    “…Detection of new highly potent synthetic opioids is challenging as new compounds enter the market. Here we present a novel screening method for the detection…”
    Get full text
    Journal Article
  12. 12

    Pharmacokinetics and pharmacodynamics of the synthetic cannabinoid, 5F-MDMB-PICA, in male rats by Krotulski, Alex J., Garibay, Nancy, Walther, Donna, Walton, Sara E., Mohr, Amanda L.A., Logan, Barry K., Baumann, Michael H.

    Published in Neuropharmacology (01-11-2021)
    “…5F-MDMB-PICA is a popular synthetic cannabinoid associated with analytically confirmed intoxications. In vitro studies show 5F-MDMB-PICA is a potent…”
    Get full text
    Journal Article
  13. 13

    Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review by Mohr, Amanda L A, Logan, Barry K, Fogarty, Melissa F, Krotulski, Alex J, Papsun, Donna M, Kacinko, Sherri L, Huestis, Marilyn A, Ropero-Miller, Jeri D

    Published in Journal of analytical toxicology (14-07-2022)
    “…Abstract An important role of modern forensic and clinical toxicologists is to monitor the adverse events of novel psychoactive substances (NPS). Following a…”
    Get full text
    Journal Article
  14. 14

    Use of synthetic stimulants and hallucinogens in a cohort of electronic dance music festival attendees by Mohr, Amanda L.A., Friscia, Melissa, Yeakel, Jillian K., Logan, Barry K.

    Published in Forensic science international (01-01-2018)
    “…•The paper describes a protocol for collection of samples from a drug user population.•The paper provides a method for pharmacoepidemiological monitoring of…”
    Get full text
    Journal Article
  15. 15

    4F‐MDMB‐BINACA: A New Synthetic Cannabinoid Widely Implicated in Forensic Casework by Krotulski, Alex J., Mohr, Amanda L.A., Kacinko, Sherri L., Fogarty, Melissa F., Shuda, Sarah A., Diamond, Francis X., Kinney, William A., Menendez, M.J., Logan, Barry K.

    Published in Journal of forensic sciences (01-09-2019)
    “…This is the first report regarding the characterization of the new synthetic cannabinoid 4F‐MDMB‐BINACA. 4F‐MDMB‐BINACA was first analytically confirmed in…”
    Get full text
    Journal Article
  16. 16

    A transnational perspective on the evolution of the synthetic cannabinoid receptor agonists market: Comparing prison and general populations by Norman, Caitlyn, Halter, Sebastian, Haschimi, Belal, Acreman, Dean, Smith, Josie, Krotulski, Alex J., Mohr, Amanda L.A., Logan, Barry K., NicDaéid, Niamh, Auwärter, Volker, McKenzie, Craig

    Published in Drug testing and analysis (01-04-2021)
    “…The synthetic cannabinoid receptor agonist (SCRA) market is transnational, and the availability of individual SCRAs changes regularly in response to national…”
    Get full text
    Journal Article
  17. 17

    Analysis of the Illicit Opioid U-48800 and Related Compounds by LC–MS-MS and Case Series of Fatalities Involving U-48800 by Fogarty, Melissa F, Mohr, Amanda L A, Papsun, Donna M, Logan, Barry K

    Published in Journal of analytical toxicology (14-02-2022)
    “…Abstract We report a method for the detection and quantitation of 12 drugs and 2 metabolites in the same structural class as the illicit mu-opioid agonist…”
    Get full text
    Journal Article
  18. 18

    Concentrations of para-Fluorofuranylfentanyl in Paired Central and Peripheral Blood Collected during Postmortem Death Investigations by Rodriguez Salas, Judith, Krotulski, Alex J, Newman, Reta, Thogmartin, Jon R, Mohr, Amanda L A, Logan, Barry K

    Published in Journal of analytical toxicology (21-04-2022)
    “…Abstract The opioid epidemic in the USA has been associated with an increasing mortality rate in large part due to the emergence and proliferation of synthetic…”
    Get full text
    Journal Article
  19. 19

    Metabolism of novel opioid agonists U‐47700 and U‐49900 using human liver microsomes with confirmation in authentic urine specimens from drug users by Krotulski, Alex J., Mohr, Amanda L. A., Papsun, Donna M., Logan, Barry K.

    Published in Drug testing and analysis (01-01-2018)
    “…Recently, the number of adverse events, including death, involving novel opioids has continued to increase, providing additional and sustained challenges for…”
    Get full text
    Journal Article
  20. 20

    Evaluating Trends in Novel Psychoactive Substances Using a Sentinel Population of Electronic Dance Music Festival Attendees by Mohr, Amanda L A, Fogarty, Melissa F, Krotulski, Alex J, Logan, Barry K

    Published in Journal of analytical toxicology (14-05-2021)
    “…Electronic dance music (EDM) festivals have become a popular venue for recreational drug use, including the use of traditional stimulants like…”
    Get full text
    Journal Article